PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'ASST Grande Ospedale Metropolitano Niguarda, Department of Neurosciences, Multiple Sclerosis Center, Piazza dell\'Ospedale Maggiore 3, 20162, Milan, Italy. lorsaraceno@gmail.com.\', \'ASST Grande Ospedale Metropolitano Niguarda, Department of Neurosciences, Multiple Sclerosis Center, Piazza dell\'Ospedale Maggiore 3, 20162, Milan, Italy.\', \'ASST Grande Ospedale Metropolitano Niguarda, Infectious Diseases Unit, Piazza dell\'Ospedale Maggiore 3, 20162, Milan, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s10072-021-05567-7
?:doi
?:hasPublicationType
?:journal
  • Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
is ?:pmid of
?:pmid
?:pmid
  • 34431013
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • SARS-CoV-2 infection after alemtuzumab in a multiple sclerosis patient: milder disease symptoms in comparison with coinfected relatives: a case report and review of the literature.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all